💉

Other Drugs

💊 Drugs 3,200 recalls

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain sulfoaildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.

Apr 10, 2013 Other Drugs Nationwide View Details →

cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy

May 1, 2013 Other Drugs Nationwide View Details →

Defective container: products are packaged in pouches which may not have been fully sealed

Jun 6, 2013 Other Drugs Nationwide View Details →

Unit Dose Mispackaging: Product packaging defect which could result in code date smearing, incomplete blister card cuts, and missing or incorrectly placed liquicaps within the blisters.

Jul 3, 2013 Other Drugs Nationwide View Details →